EvokAI Creative Labs (TSXV:OKAI) 1-Year Sharpe Ratio: -86.83 (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:OKAI EvokAI Creative Labs Inc TSXV:OKAI
15 GF Score
Price C$0.12
View Full Analysis

What is EvokAI Creative Labs 1-Year Sharpe Ratio?

EvokAI Creative Labs TSXV:OKAI 15 1-Year Sharpe Ratio is -86.83 as of Aug. 03, 2026. GuruFocus rates TSXV:OKAI with a GF Score™ of 15/100.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-03), EvokAI Creative Labs's 1-Year Sharpe Ratio is -86.83.

EvokAI Creative Labs  (TSXV:OKAI) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

EvokAI Creative Labs 1-Year Sharpe Ratio Related Terms

TSXV:OKAI vs VEEV, GEHC, DOCS: 1-Year Sharpe Ratio Comparison

For the Health Information Services subindustry, EvokAI Creative Labs's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EvokAI Creative Labs 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EvokAI Creative Labs's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where EvokAI Creative Labs's 1-Year Sharpe Ratio falls into.


TSXV:OKAI
15GF Score
EvokAI Creative Labs Inc TSXV:OKAI
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EvokAI Creative Labs 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -86.83 mean?
EvokAI Creative Labs (TSXV:OKAI) has a 1-Year Sharpe Ratio of -86.83 as of Aug. 03, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for EvokAI Creative Labs and its competitors.
Is EvokAI Creative Labs' 1-Year Sharpe Ratio too high?
EvokAI Creative Labs' current 1-Year Sharpe Ratio is -86.83. Overall, EvokAI Creative Labs has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does EvokAI Creative Labs' 1-Year Sharpe Ratio compare to VEEV and GEHC?
EvokAI Creative Labs' 1-Year Sharpe Ratio of -86.83 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for EvokAI Creative Labs and its competitors. EvokAI Creative Labs's current 1-Year Sharpe Ratio is -86.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EvokAI Creative Labs stock overvalued right now?
EvokAI Creative Labs (TSXV:OKAI) has a current 1-Year Sharpe Ratio of -86.83. The current 1-Year Sharpe Ratio is -86.83. EvokAI Creative Labs' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For EvokAI Creative Labs (TSXV:OKAI), the current 1-Year Sharpe Ratio is -86.83 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EvokAI Creative Labs Business Description

Address 609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
15GF Score

Get the complete analysis for TSXV:OKAI

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.12
Price